Immunotherapeutic Challenges and Treatment Resistance in Glioma
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Nervous System".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 252
Special Issue Editor
Special Issue Information
Dear Colleagues,
The field of neuro-oncology and the treatment of gliomas have been drastically changing over the past decade. This is largely driven by the wealth of molecular investigations characterizing these tumors, intratumoral heterogeneity, and better understood mechanisms of glioma treatment resistance. With this information, this field has dedicated a great deal of effort to employing immunotherapy to treat these tumors. However, clinical trials and preclinical investigations of translational therapies have yielded several challenges to effectively using immunotherapy’s full potential. In this Special Issue, the focus will be on detailing these mechanisms of immunotherapeutic treatment resistance. The aim of this Special Issue is to provide an overview of these discoveries and how they will inform the natural biology of these tumors so that we can advance the targeting of these tumors.
Dr. Kristen A. Batich
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antigen presentation
- innate immunity
- cellular immunotherapy
- treatment resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
